Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: S01ED51

Azarga(brinzolamide;timolol maleate)

Glaucoma, Open-Angle;Ocular Hypertension

Marketing Authorisation Holder: Novartis Europharm Limited

EMA Authorisation: 25/11/2008

INN: brinzolamide;timolol

Indication

Decrease of intraocular pressure (IOP) in adult patients with open angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Azarga — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.